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Glomerular -galactosidase expression following transduction lowed by local protein synthesis. Alternatively, inciden-
with microsphere-adenoviral complexes. The aortic injection tal liver transduction may also result in glomerular trans-
of adenoviral-microsphere complexes is a useful technique for protein expression [2]. This is thought to occur secondaryin vivo gene transfer (transduction) to the glomerulus. In this
to hepatic synthesis of the transprotein, followed by se-approach, the appearance of the foreign transprotein in the
cretion and subsequent deposition in glomeruli [2]. Inglomerulus may result from glomerular cell gene transfer and
local synthesis or hepatic cell transduction followed by synthe- these studies, we investigated glomerular transgene ex-
sis, secretion, and deposition in the glomerulus. We postulated pression in transduced rats using reverse transcription
that glomerular expression of the foreign transgene was the (RT) in situ polymerase chain reaction (PCR). Theseresult of glomerular cell transduction. To test this question,
studies suggest that following transduction with adenovi-male SD rats underwent aortic injections with adenovirus con-
ral-microsphere complexes, the expression of glomerulartaining the LacZ expression cassette [expressing -galactosi-
dase (gal)] coupled to 16 m diameter microspheres. After transprotein results from glomerular DNA transfer and
48 hours, histologic staining confirmed glomerular expression local synthesis.
of the gal transprotein and reverse transcription in situ poly-
merase chain reaction demonstrated the presence of the gal
transgene in the glomerulus. In addition, hepatic expression METHODS
of the gal transprotein was minimal and substantially less
Adenoviral constructs and transduction protocolthan that observed in the glomeruli. These data support the
contention that adenoviral-microsphere complexes result in Preparation of replication-deficient recombinant ade-
glomerular cell transduction with the desired transgene, fol-
novirus. Replication-deficient recombinant adenoviruslowed by local transprotein synthesis. This approach may prove
used in these studies were prepared as we have describeduseful for facilitating glomerular gene transfer in the develop-
ment of gene therapy for glomerulonephritis. in detail elsewhere [3]. In brief, viral stocks of adenovirus
containing expression cassettes composed of the cyto-
megalovirus immediate early promoter fused to the lacZ
The development of useful approaches to gene ther- reporter gene (rAvgal, a generous gift of Dr. Phil John-
apy of glomerular disease depends on the accurate deliv- son, Children’s Hospital, Columbus, OH, USA) or the
ery of DNA constructs to the glomerulus, followed by distal 459 bp [of the human transforming growth factor-1
gene transfer and transcription. In previous studies, we gene promoter (a generous gift of Dr. Seong Kim, Na-
used adenoviral-microsphere complexes to facilitate DNA tional Institutes of Health, Bethesda, MD, USA) fused
transfer (transduction) into glomerular cells [1]. Using to a luciferase reporter gene (rAvTGF), were used in
this approach, up to 19% of glomeruli exhibited the these studies.
transprotein for 21 days [1]. In this work, glomerular Adenoviral-microsphere complexes. Adenoviral-micro-
transduction resulted from (1) glomerular capillary tar- sphere complexes were prepared as we have described
geting from microparticle embolization and (2) subse- [1]. In brief, rAvgal and rAvTGF (2  108 total parti-
quent viral contact with mesangial and endothelial cells. cles) were incubated with 1  106 16 m diameter fluo-
We have postulated that glomerular transprotein ex- rescent polystyrene microspheres (Duke Scientific Corp.,
pression following injection of microsphere–adenoviral Palo Alto, CA, USA) in alkaline borate buffer [4] and
complexes represents glomerular cell transduction, fol- were washed, resuspended in sterile phosphate-buffered
saline (PBS), and used for in vivo transduction.
In vivo transduction. Male Sprague-Dawley rats ofKey words: glomerulonephritis, transduction, -galactosidase, adeno-
vectors, gene therapy, in situ PCR. 300 to 350 g (Harlan-Sprague Dawley, Indianapolis, IN,
USA) were anesthetized with ketamine/xylazine; the left 2002 by the International Society of Nephrology
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carotid artery was identified and cannulated via a small TCGGATTCT-3) of gal mRNA (GIBCO), 20 cycles
of PCR were performed. The slides were washed at highcervical-thoracic incision and the animals transduced by
stringency, and the digoxigenin was labeled. Target-spe-aortic injection of 1 mL of PBS containing either adeno-
cific cDNA was detected after incubation with 1:200 anti-viral-microsphere complexes, free adenovirus, or micro-
digoxigenin-alkaline phosphotase conjugate (Boehringerspheres alone [1]. The proximal carotid artery was ligated
Mannheim) followed by exposure to nitroblue tetrazo-as the catheter was removed, and the incision was closed
lium and bromochloroindolyl phosphate chromogenswith wound clips. After 48 hours, all animals were sacri-
(Enzo Biochemicals, Farmingdale, NY, USA). The tis-ficed, and samples of kidney and liver were taken for
sues were counterstained with nuclear fast red. Controlsassessment of transgene activity.
for RT in situ PCR included no DNase treatment, the
Determination of transgene expression omission of primers, the use of irrelevant human papillo-
mavirus-specific primers, and RNase digestion prior toHistologic preparations for bgal activity. Histologic
RT in situ PCR. gal mRNA was indicated by the pres-preparations of full longitudinal kidney sections, or por-
ence of a blue precipitate.tions of liver from transduced rats, were prepared as we
Light microscopic analysis of transduced tissue. Eachhave described [1]. In brief, the organs were removed
tissue section was examined blindly under light micros-at sacrifice, bisected, and one half of the tissue mass snap
copy. In this analysis, all kidney and liver sections werefrozen in liquid nitrogen. The remaining portion of the
examined for expression of the gal transgene. The sur-organ was frozen in cryoprotective medium (OCT; Sa-
face area of gal-positive regions was determined withkura Finetek, Torrance, CA, USA) and stored at 70C
an image analysis software program (Jandel, SigmaScan-until sectioned. Cryosections (6 m) were fixed with 2%
Pro, San Rafael, CA, USA) and was expressed as aparaformaldehyde in a 100 mmol/L phosphate buffer
percent of the total tissue area.(pH 7.4) for 5 minutes at 4C. The sections were washed
twice in PBS and stained at 37 for four to six hours in Statistical analysis
a 100 mmol/L sodium phosphate solution containing 1.3
All data are expressed as mean  SD. Differences inmmol/L MgCl2, 3 mmol/L K3Fe(CN)6, 3 mmol/L K4Fe transgene expression were assessed using Student’s t test(CN)6, and 1 mg/mL 5-bromo-4-chloro-3-indolyl--D- and were considered significant at P  0.05.galactoside (X-gal). The sections were counterstained
with nuclear fast red. The sections were examined by
RESULTSvisual inspection and analyzed using digital image analy-
sis (discussed later in this article). Kidney and liver transprotein levels from
Luciferase activity from transduced tissue. Luciferase transduced rats
activity from liver and kidney of transduced rats was Table 1 indicates kidney and liver transprotein levels
determined after snap freezing the sample in liquid nitro- from transduced rats. Transprotein levels from animals
gen, pulverizing at 70C, and solubilizing in the pres- injected with adenoviral-microsphere complexes were
ence of cell lysis buffer (2.5 mL/g tissue). After incuba- substantially greater in the kidney relative to the liver.
tion for 30 minutes at 4C and centrifugation at 1500 When compared with rats injected with adenoviral-micro-
rpm for 10 minutes, the supernatant was recovered and sphere complexes, animals injected with free adenovirus
stored at 70C. Luciferase levels were determined by demonstrated a significant increase in hepatic transpro-
mixing 20 L of tissue extract with 100 L of luciferase tein expression, with relative sparing of the kidney.
assay substrate from Promega (Madison, WI, USA) and Figure 1 shows representative histologic sections dem-
reading immediately in a Lumat LB 9501 luminometer onstrating expression of the gal transprotein from trans-
from Wallac (Gaithersburg, MD, USA). duced rats. In rats injected with adenoviral-microsphere
Glomerular expression of bgal mRNA in transduced complexes, kidney expression of the gal transprotein
rats. Glomerular expression of the gal transgene was was limited to the glomeruli (Fig. 1A) and was not seen
documented in vivo using RT in situ PCR. The method in the tubular or vascular compartments. The remainder
is summarized briefly in the following [1]: Four micron of the kidney was normal and without evidence of isch-
cryostat kidney sections from a wild-type and transduced emia. Hepatic transduction was rare and limited to the
rat were fixed in 10% buffered formalin, washed, air occasional hepatocyte (Fig. 1B). In contrast, rats injected
dried, protease digested, incubated overnight in RNase with free adenovirus had no kidney gal expression but
free-DNase (Boehringer Mannheim, Indianapolis, IN, demonstrated extensive hepatic gal activity (Fig. 1 C,
USA), and subjected to one-step RT-PCR using the rTth D, respectively).
system and digoxigenin dUTP as we have described
Glomerular transgene expression from transduced rats[5, 6]. Using primers recognizing the 5 forward terminus
(5-CCGTCGTTTTACAACGTCGTGA-3) and 3 re- To confirm successful delivery of the gal transgene
to the kidney, RT in situ PCR for the lac Z gene sequenceverse terminus (5-ATGTGAGCGAGTAACAACCG
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Table 1. Kidney and liver transprotein activities from rats injected with adenoviral-microsphere complexes or free adenovirus
Adenoviral-microsphere complexes (N 	 4) Free adenovirus (N 	 2)
Organ gal expressiona Luciferase levelb gal expression Luciferase level
Kidney 1.530.9c 680176d 0 1036
Liver 0.10.08d 378130d 5.74.2 238,000180,000
a Percent of total surface area. Determined using digital image analysis (see Methods).
b Arbitrary units per mg of tissue
cgal activity was limited exclusively to the glomeruli and is expressed as a percent of the cumulative surface area of all glomeruli on each section
d P  0.05 when compared with rats injected with free adenovirus
Fig. 1. Kidney and liver sections demonstra-
ting the patterns of histologic expression of the
gal transprotein from rats transduced with
adenoviral-microsphere complexes (A and B)
or free adenovirus (C and D). (A) Representa-
tive glomerulus demonstrating extensive gal
expression (blue pigment) (400). (B) Repre-
sentative liver section from the same rat show-
ing a single transduced hepatocyte (400).
(C) Glomerulus showing no transprotein ex-
pression (no glomeruli from this rat exhibited
any gal activity). (D) Representative liver
section demonstrating multiple foci of trans-
duction (100).
was performed on kidneys isolated from rats injected not due to hepatic cell transduction, synthesis, and glo-
merular deposition.with microsphere-adenoviral complexes or control ani-
In these studies, we used RT in situ PCR to documentmals treated with microspheres alone. In rats transduced
expression of the gal transgene in the glomeruli fromwith microsphere-adenoviral complexes RT in situ PCR
transduced rats. Control animals injected with micro-indicated glomerular localization of the transgene. Rep-
spheres lacking the virus did not exhibit gal gene ex-resentative photomicrographs are presented in Figure 2.
pression. In addition, two rats injected with free adenovi-
rus demonstrated extensive hepatic cell transduction
DISCUSSION with no transprotein expression in the kidney. Taken
This study demonstrated foreign transprotein (gal) together, these data strongly support the contention that
in the glomeruli of rats transduced with adenoviral- the gal protein detected in the glomeruli of rats trans-
microsphere complexes. The results of this work suggest duced with adenoviral-microsphere complexes was the
that the appearance of the transprotein was the result result of viral infection of the glomerulus, followed by
local transprotein protein production, and not a conse-of glomerular cell transduction and local synthesis and
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Fig. 2. RT in situ PCR demonstrating expres-
sion of the gal transgene in the glomerulus
from a rat transduced with microspheres com-
plexed to adenovirus containing a CMV-lacZ
expression cassette. (A) Glomerular tuft show-
ing diffuse expression of gal mRNA (dense
blue pigment). (B) Higher power view of (A)
demonstrating gal expression (white arrows)
and pink cell nucleus (black arrow). (C) Con-
trol section probed with irrelevant primers.
(D) Control section not subjected to DNAase
I treatment. The expected diffuse blue pig-
mentation is evident (A, C, and D, 1000; B,
3000; MS, microsphere).
quence of hepatic synthesis (or release from immune ular ischemia from insoluble microspheres, and (3) lim-
ited duration of transgene activity. Extra renal transduc-hepatocyte destruction [7]), with secondary deposition
in the glomeruli [2]. tion events could be reduced with selective renal artery
injection. Aortic injections are relatively simple and non-In previous studies, we showed that the aortic injection
of adenoviral-microsphere complexes was well tolerated, invasive when studying small animals such as rats. Glo-
merular ischemia from prolonged microsphere emboliza-transduced up to 19% of glomeruli, and resulted in sus-
tained transprotein activity for approximately 21 days tion is a theoretical risk that could be reduced with the
use of biodegradable microparticles such as albumin,[1]. Others have reported successful gene transfer into
the glomerulus using continuous organ perfusion with casein, or polyester [15–17]. Finally, the duration of
transgene expression can be improved with the use of lessadenovirus [8], injection of liposome complexes [9–12],
or transfected mesangial cell vectors [13, 14]. Each of immunogenic viruses (“gutless” adenoviruses) [18, 19].
In summary, the aortic injection of adenoviral-micro-these studies used laparotomy and selective renal artery
cannulation and were thus more invasive than our sphere complexes is a useful approach to glomerular
gene delivery in rats. Transprotein activity in the glomer-method.
The aortic injection of adenoviral-microsphere com- ulus is primarily the result of local synthesis and appears
to be independent of hepatic transprotein synthesis, se-plexes for glomerular transduction represents a feasible
approach to glomerular gene transfer, but is limited by cretion, and glomerular deposition. Technical advances
with biodegradable particles and novel adenoviruses give(1) extra renal transduction [1], (2) potential for glomer-
Bhatt et al: Glomerular expression of a bgal transgeneS-72
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